Baird Medical Investment Holdings Limited (BDMD) Shares Decline Despite Market Challenges

Baird Medical Investment Holdings Limited (NASDAQ: BDMD)’s stock price has gone decline by -13.50 in comparison to its previous close of 6.74, however, the company has experienced a -19.92% decrease in its stock price over the last five trading days. prnewswire.com reported 2025-02-03 that NEW YORK, Feb. 3, 2025 /PRNewswire/ — Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” or the “Company”), a leader in microwave ablation (MWA) technology, made a significant impact at the 2025 North American Society for Interventional Thyroidology (NASIT) conference.

Is It Worth Investing in Baird Medical Investment Holdings Limited (NASDAQ: BDMD) Right Now?

Moreover, the 36-month beta value for BDMD is -0.69.

The public float for BDMD is 35.39M and currently, short sellers hold a 0.27% of that float. On February 05, 2025, BDMD’s average trading volume was 2.07M shares.

BDMD’s Market Performance

BDMD’s stock has seen a -19.92% decrease for the week, with a 13.87% rise in the past month and a 114.34% gain in the past quarter. The volatility ratio for the week is 16.65%, and the volatility levels for the past 30 days are at 33.47% for Baird Medical Investment Holdings Limited The simple moving average for the past 20 days is -21.54% for BDMD’s stock, with a -26.66% simple moving average for the past 200 days.

BDMD Trading at 32.61% from the 50-Day Moving Average

After a stumble in the market that brought BDMD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -56.88% of loss for the given period.

Volatility was left at 33.47%, however, over the last 30 days, the volatility rate increased by 16.65%, as shares sank -3.48% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +138.93% upper at present.

During the last 5 trading sessions, BDMD fell by -19.92%, in comparison to the 20-day moving average, which settled at $7.43. In addition, Baird Medical Investment Holdings Limited saw -23.29% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for BDMD

Current profitability levels for the company are sitting at:

  • 0.14 for the present operating margin
  • 0.87 for the gross margin

The net margin for Baird Medical Investment Holdings Limited stands at 0.15. The total capital return value is set at 0.05. Equity return is now at value -25.39, with -14.19 for asset returns.

Based on Baird Medical Investment Holdings Limited (BDMD), the company’s capital structure generated 0.28 points at debt to capital in total, while cash flow to debt ratio is standing at -0.31.

Currently, EBITDA for the company is 12.85 million with net debt to EBITDA at 4.04. When we switch over and look at the enterprise to sales, we see a ratio of 16.8. The receivables turnover for the company is 0.38for trailing twelve months and the total asset turnover is 0.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.02.

Conclusion

To wrap up, the performance of Baird Medical Investment Holdings Limited (BDMD) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts